Alternative medicine only treatment linked to lower cancer survival

Yale University researchers warn in a new study that alternative therapies for treatment of curable cancers carry a significantly higher risk of death.
Source: Health News - - Category: Consumer Health News Source Type: news

Related Links:

Conclusions. Aidi injection plus docetaxel-based chemotherapy, especially plus DP, DC, and DO, may significantly improve the clinical efficacy and QOL in NSCLC. It may also have low risk of hematotoxicity, gastrointestinal toxicity, and low risk of inducing hepatorenal dysfunctions. Aidi injection may have attenuation and synergistic efficacy to docetaxel chemotherapy. All these need to have new evidence to be proved. PMID: 29991956 [PubMed]
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
S. B. Johnson, H. S. Park, C. P. Gross and J. B. Yu
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Urological Survey Source Type: research
Publication date: July 2018Source: Saudi Journal of Biological Sciences, Volume 25, Issue 5Author(s): Ye Jin, Xue Meng, Zhidong Qiu, Yanping Su, Peng Yu, Peng QuAbstractPublic interest in complementary and alternative medicine has been increased worldwide, due to its wide applications in cancer prevention and treatment. Cordycepin is one of the most common and crucial types of complementary and alternative medicine. Cordycepin (3′-deoxyadenosine), a derivative of adenosine, was first isolated from medicine drug Cordyceps militaris. Cordycepin has been widely used as one compound for antitumor, which has been found to...
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research
This study also deals with the effect of E. triaculeata on the standard drug cyclophosphamide (CP) treatment in mice. Three different doses 250, 500 and 1000 mg/kg body weight were selected. In micronucleus assay, single oral dose administration of Euphorbia triaculeata extract at the three doses did not increase the number of micronucleated polychromatic erythrocytes. Similarly, a single oral administration of Euphorbia triaculeata extract showed no significant changes on mitotic indices or in induction of chromosomal aberrations in mice bone marrow cells. Pretreatment with E. triaculeata extract significantly reduced t...
Source: Toxicology Reports - Category: Toxicology Source Type: research
The objective of this study was to review the use of taping as an alternative/complementary treatment to reduce lymphedema. A literature review was conducted of scientific articles indexed on the PubMed, LILACS, MEDLINE, and PEDro databases and Google Scholar, and nine articles were selected. It was found that taping is a complementary therapy for reducing lymphedema, which may be used as an alternative treatment method, but cannot substitute multilayer compression therapy.
Source: Jornal Vascular Brasileiro - Category: Surgery Source Type: research
ConclusionsThe experimental results from the pharmacological research enable the validation of their traditional uses in several of the groups of diseases in the countries of origin and reveal these plants to be a valuable source for therapeutic molecules. However, more toxicity assays and clinical trials would be necessary to establish optimal and safe doses of consumption on the application of these medicinal plants.Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
In conclusion, dual-treatments based on Lms and/or Tau are promising therapies for cancer, not only due to its abilities to induce apoptosis in the tumor cells and modulate the immune response against them, but also due to its capabilities to potentiate the chemotherapy anticancer efficacy and minimize its adverse effects.Graphical abstract
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 23 June 2018Source: Integrative Medicine ResearchAuthor(s): Mohamed K.M. Khalil, Sulaiman Al-Eidi, Meshary Al-Qaed, Saud AlSanadAbstractSaudi Arabia is witnessing a healthcare transformation to face the challenges of the increased burden of noncommunicable diseases and to maintain the quality of healthcare services. However, in Saudi Arabia, where low back and neck pain, depressive disorders, migraine, diabetes, and anxiety disorders cause the most disability, a broader way of integrative health approach is needed to foster healthy lives and promote well-being for all ages. In the presenc...
Source: Integrative Medicine Research - Category: Complementary Medicine Source Type: research
This report describes a 62-year-old Korean woman with lung metastases from HCC. She first underwent surgery (stage IV) and six cycles of adjuvant chemotherapy. She was subsequently treated with sorafenib, but computed tomography showed progressive disease and she experienced the side effects of sorafenib. The patient started treatment with TKM, including pharmacopuncture and herbal medicine, in addition to sorafenib. After 8 weeks of TKM treatment, the size of the metastatic nodules decreased and the sorafenib-associated side effect symptoms improved. These findings suggest that treatment with a combination of TKM and sora...
Source: EXPLORE: The Journal of Science and Healing - Category: Complementary Medicine Source Type: research
Publication date: Available online 22 April 2018Source: EXPLOREAuthor(s): Eran Ben-Arye, Ilana Doweck, Elad Schiff, Noah SamuelsAbstractContextChemotherapy-induced taste disorder (CITD) is a common adverse effect among patients with cancer, with no effective known treatment.ObjectivesExploring the impact of a patient-tailored complementary and integrative medicine (CIM) treatment program on CITD-related severity.DesignProspective study on patients’ chart.SettingIntegrative oncology program operating within the Clalit Healthcare Oncology Service in northern Israel.PatientsPatients were referred by their oncology healt...
Source: EXPLORE: The Journal of Science and Healing - Category: Complementary Medicine Source Type: research
More News: Alternative and Complementary Therapies | Cancer | Cancer & Oncology | Complementary Medicine | Health | Study | Yale